Korea hypertension fact sheet 2020: analysis of nationwide population-based data.
Antihypertensive medication
Awareness
Control
Hypertension
Korea
Prevalence
Treatment
Journal
Clinical hypertension
ISSN: 2056-5909
Titre abrégé: Clin Hypertens
Pays: England
ID NLM: 101669508
Informations de publication
Date de publication:
15 Mar 2021
15 Mar 2021
Historique:
received:
29
12
2020
accepted:
04
03
2021
entrez:
15
3
2021
pubmed:
16
3
2021
medline:
16
3
2021
Statut:
epublish
Résumé
The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2020 to provide an overview of the magnitude and management status of hypertension and their recent trends. The Fact Sheets were based on the analyses of Korean adults aged 20 years or older of the 2007-2018 Korea National Health and Nutrition Examination Survey (KNHANES) and the 2002-2018 National Health Insurance Big Data (NHI-BD). Currently, the population average of systolic/diastolic blood pressure was 118/76 mmHg in Korean adults aged 20 years or older showing little change in the recent decade. However, the number of people with hypertension increased steadily, exceeding 12.0 million. Indeed, the number of people diagnosed with hypertension increased from 3.0 million in 2002 to 9.7 million in 2018. During the same period, the number of people using antihypertensive medication increased from 2.5 million to 9.0 million, and the number of people adherent to treatment increased from 0.6 million to 6.5 million. Hypertension awareness, treatment, and control rates increased rapidly until 2007, but showed plateaued thereafter. In 2018, the awareness, treatment, and control rates of hypertension among all adults were 67, 63, and 47%, respectively. However, the awareness and treatment rates were only 17 and 14% among adults aged 20 to 39 years old with hypertension. Among patients treated for hypertension, 61% of them were also using glucose-lowering or lipid-lowering drugs. Among antihypertensive prescriptions, 41% of the patients received monotherapy, 43% received dual therapy, and 16% received triple or more therapy. The most commonly prescribed antihypertensive medication was angiotensin receptor blockers, followed by calcium channel blockers and diuretics. To achieve further improvement in management of hypertension, we need to encourage awareness and treatment in young adults. It is required to develop tailored prevention and management strategies that are appropriate for and inclusive of various demographics.
Sections du résumé
BACKGROUND
BACKGROUND
The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2020 to provide an overview of the magnitude and management status of hypertension and their recent trends.
METHODS
METHODS
The Fact Sheets were based on the analyses of Korean adults aged 20 years or older of the 2007-2018 Korea National Health and Nutrition Examination Survey (KNHANES) and the 2002-2018 National Health Insurance Big Data (NHI-BD).
RESULTS
RESULTS
Currently, the population average of systolic/diastolic blood pressure was 118/76 mmHg in Korean adults aged 20 years or older showing little change in the recent decade. However, the number of people with hypertension increased steadily, exceeding 12.0 million. Indeed, the number of people diagnosed with hypertension increased from 3.0 million in 2002 to 9.7 million in 2018. During the same period, the number of people using antihypertensive medication increased from 2.5 million to 9.0 million, and the number of people adherent to treatment increased from 0.6 million to 6.5 million. Hypertension awareness, treatment, and control rates increased rapidly until 2007, but showed plateaued thereafter. In 2018, the awareness, treatment, and control rates of hypertension among all adults were 67, 63, and 47%, respectively. However, the awareness and treatment rates were only 17 and 14% among adults aged 20 to 39 years old with hypertension. Among patients treated for hypertension, 61% of them were also using glucose-lowering or lipid-lowering drugs. Among antihypertensive prescriptions, 41% of the patients received monotherapy, 43% received dual therapy, and 16% received triple or more therapy. The most commonly prescribed antihypertensive medication was angiotensin receptor blockers, followed by calcium channel blockers and diuretics.
CONCLUSION
CONCLUSIONS
To achieve further improvement in management of hypertension, we need to encourage awareness and treatment in young adults. It is required to develop tailored prevention and management strategies that are appropriate for and inclusive of various demographics.
Identifiants
pubmed: 33715619
doi: 10.1186/s40885-021-00166-2
pii: 10.1186/s40885-021-00166-2
pmc: PMC7958489
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8Investigateurs
Hyeon Chang Kim
(HC)
Song Vogue Ahn
(SV)
Sun Ha Jee
(SH)
Sungha Park
(S)
Hae-Young Lee
(HY)
Min Ho Shin
(MH)
Sang-Hyun Ihm
(SH)
Seung Won Lee
(SW)
Hokyou Lee
(H)
Jong Ku Park
(JK)
Il Suh
(I)
Tae-Yong Lee
(TY)
So Mi Jemma Cho
(SMJ)
Hyeok-Hee Lee
(HH)
Jongmin Baek
(J)
Ji Eun Heo
(JE)
Commentaires et corrections
Type : ErratumIn
Références
Lopez AD, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–57.
doi: 10.1016/S0140-6736(06)68770-9
Feigin VL, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet Neurol. 2016;15:913–24.
doi: 10.1016/S1474-4422(16)30073-4
Levenson JW, et al. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol. 2002;5:188–99.
doi: 10.1111/j.1520-037X.2002.00564.x
Korea S. Causes of death statistics in 2019. Daejon: Statistics Korea; 2012.
National Health Insurance Service. The 2019 statistical yearbook on the usage of medical services by region. Wonju: National Health Insurance Service; 2020.
Korean Society Hypertension (KSH); Hypertension Epidemiology Research Working Group, Kim HC, Cho MC. Korea hypertension fact sheet 2018. Clin Hypertens. 2018;24:13.
doi: 10.1186/s40885-018-0098-0
Kweon S, et al. Data resource profile: the Korea National Health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43:69–77.
doi: 10.1093/ije/dyt228
Seong SC, et al. Data resource profile: the national health information database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2016;46:799–800.
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199–206.
doi: 10.1001/jama.290.2.199